Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
6,645.00Prev. Close
6,621.50Volume
2,95,492Total traded value
196 CrUpper Circuit
7,283.50Lower Circuit
5,959.50Fundamentals
| Market Cap | ₹1,75,706Cr |
| ROE | 14.64% |
| P/E Ratio(TTM) | 76.19 |
| EPS(TTM) | 86.87 |
| P/B Ratio | 11.74 |
| Dividend Yield | 0.45% |
| Industry P/E | 34.99 |
| Book Value | 563.87 |
| Debt to Equity | 0.00 |
| Face Value | 2 |
Understand Fundamentals
Financials
About Divi's Labs
Divi's Laboratories is a leading global manufacturer of Active Pharmaceutical Ingredients (APIs), serving as a reliable partner for major pharmaceutical companies worldwide. The company operates on the core principle of creating value for all stakeholders through sustainable leadership in chemistry and high-quality production. This strong focus has positioned Divi's among the top three API manufacturers globally, demonstrating its significant market presence and scale.;
| Parent Organisation | Divi's Laboratories Limited |
| Managing Director | Dr. Murali Divi |
| NSE Symbol | DIVISLAB |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Top Mutual Funds Invested(4)
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Neuland Laboratories | NA (0.00%) | 118.64 | ||
| Jubilant Pharmova | NA (0.00%) | 37.61 | ||
| Acutaas Chemicals | NA (0.00%) | 59.72 | ||
| Aarti Drugs | NA (0.00%) | 25.23 |